{"id":"W2024548912","doi":"10.1002/cncr.27674","title":"Phase 3, randomized, placebo‐controlled study of zibotentan (ZD4054) in patients with castration‐resistant prostate cancer metastatic to bone","year":2012,"lang":"en","type":"article","venue":"Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Placebo; Clinical endpoint; Hazard ratio; Peripheral edema; Internal medicine; Adverse effect; Bone pain; Randomized controlled trial; Common Terminology Criteria for Adverse Events; Population; Cancer; Surgery; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005435409,0.0002460464,0.001182614,0.0002646423,0.00005773471,0.00001624631,0.00006705323,0.000030217,0.0002911258],"category_scores_gemma":[0.00007399004,0.0001473602,0.00008761397,0.0004457515,0.0000949762,0.0001690243,0.00002921113,0.0001555718,0.000005662927],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000443175,"about_ca_system_score_gemma":0.0003387938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001214514,"about_ca_topic_score_gemma":0.0009783962,"domain_scores_codex":[0.9978219,0.0001990053,0.000567402,0.0002867212,0.0006118711,0.0005131394],"domain_scores_gemma":[0.9988537,0.0001123802,0.0001947293,0.0002581327,0.0002807761,0.0003002458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8351043,0.007034202,0.1450014,0.0001550613,0.001078003,0.00004032412,0.00637442,0.000134724,0.00115237,0.000008444056,0.0002312381,0.003685482],"study_design_scores_gemma":[0.9519105,0.002974965,0.04074229,0.0003032846,0.0009119217,0.000001146681,0.001403993,0.00005684845,0.001395114,0.00000453083,0.0001027337,0.0001926778],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985742,0.003144138,0.000009923192,0.000375157,0.0001516325,0.01027426,0.0001121252,0.00001693243,0.0001737887],"genre_scores_gemma":[0.9933764,0.000174179,0.0001341276,0.0001064905,0.00006874138,0.004562741,0.00003418393,0.00003564756,0.001507512],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1168062,"threshold_uncertainty_score":0.6009175,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02518159830858788,"score_gpt":0.3572338929697615,"score_spread":0.3320522946611736,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}